Literature DB >> 14389741

Agranulocytosis from carbimazole.

A BATTY SHAW.   

Abstract

Entities:  

Keywords:  AGRANULOCYTOSIS/etiology and pathogenesis; THYROID ANTAGONISTS/injurious effects

Mesh：

Substances：

Year:  1955        PMID： 14389741      PMCID： PMC1980440          DOI： 10.1136/bmj.2.4933.246

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  6 in total

1.  Carbimazole in thyrotoxicosis.

Authors:  K KIRKEBY; O RØMCKE
Journal:  Lancet       Date:  1955-02-18       Impact factor: 79.321

2.  Antithyroid activity and toxicity of mercazole and neo-mercazole.

Authors:  T R FRASER; O GARROD; M G HANNO; A JADRESIC
Journal:  J Clin Endocrinol Metab       Date:  1954-10       Impact factor: 5.958

3.  Agranulocytosis in a patient treated with carbimazole.

Authors:  A R HARRISON
Journal:  Lancet       Date:  1954-02-20       Impact factor: 79.321

4.  Fatal case of marrow aplasia after treatment with carbimazole; the effect of ACTH.

Authors:  J S RICHARDSON; I SARKANY; C D CAMPBELL
Journal:  Br Med J       Date:  1954-02-13

5.  Treatment of thyrotoxicosis with neo mercazole (2-carbethoxythio-1-methylglyoxaline; report of 120 cases.

Authors:  D DONIACH
Journal:  Lancet       Date:  1953-05-02       Impact factor: 79.321

6.  Thyrotoxicosis treated with 2-carbethoxythio-1-methylglyoxaline (neo mercazole).

Authors:  H POATE
Journal:  Lancet       Date:  1953-05-02       Impact factor: 79.321
  6 in total
  1 in total

1.  Carbimazole (neo-mercazole) in thyrotoxicosis--a review of sixty patients.

Authors:  M W BOYD
Journal:  Ulster Med J       Date:  1959-11-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.